IBDEI36R ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,53495,0)
 ;;=99442^^246^2689^2^^^^1
 ;;^UTILITY(U,$J,358.3,53495,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,53495,1,1,0)
 ;;=1^99442
 ;;^UTILITY(U,$J,358.3,53495,1,2,0)
 ;;=2^PHONE E/M 11-20 MIN
 ;;^UTILITY(U,$J,358.3,53496,0)
 ;;=98966^^246^2690^1^^^^1
 ;;^UTILITY(U,$J,358.3,53496,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,53496,1,1,0)
 ;;=1^98966
 ;;^UTILITY(U,$J,358.3,53496,1,2,0)
 ;;=2^PHONE CALL BY HC PROF 5-10 MIN
 ;;^UTILITY(U,$J,358.3,53497,0)
 ;;=98967^^246^2690^2^^^^1
 ;;^UTILITY(U,$J,358.3,53497,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,53497,1,1,0)
 ;;=1^98967
 ;;^UTILITY(U,$J,358.3,53497,1,2,0)
 ;;=2^PHONE CALL BY HC PROF 11-20 MIN
 ;;^UTILITY(U,$J,358.3,53498,0)
 ;;=98968^^246^2690^3^^^^1
 ;;^UTILITY(U,$J,358.3,53498,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,53498,1,1,0)
 ;;=1^98968
 ;;^UTILITY(U,$J,358.3,53498,1,2,0)
 ;;=2^PHONE CALL BY HC PROF 21-30 MIN
 ;;^UTILITY(U,$J,358.3,53499,0)
 ;;=E13.9^^247^2691^9
 ;;^UTILITY(U,$J,358.3,53499,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,53499,1,3,0)
 ;;=3^Diabetes Mellitus w/o Complications,Other Spec
 ;;^UTILITY(U,$J,358.3,53499,1,4,0)
 ;;=4^E13.9
 ;;^UTILITY(U,$J,358.3,53499,2)
 ;;=^5002704
 ;;^UTILITY(U,$J,358.3,53500,0)
 ;;=R93.8^^247^2691^2
 ;;^UTILITY(U,$J,358.3,53500,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,53500,1,3,0)
 ;;=3^Abnormal Findings on Diagnostic Imaging of Body Structures
 ;;^UTILITY(U,$J,358.3,53500,1,4,0)
 ;;=4^R93.8
 ;;^UTILITY(U,$J,358.3,53500,2)
 ;;=^5019721
 ;;^UTILITY(U,$J,358.3,53501,0)
 ;;=R94.8^^247^2691^4
 ;;^UTILITY(U,$J,358.3,53501,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,53501,1,3,0)
 ;;=3^Abnormal Results of Function Studies of Organs/Systems
 ;;^UTILITY(U,$J,358.3,53501,1,4,0)
 ;;=4^R94.8
 ;;^UTILITY(U,$J,358.3,53501,2)
 ;;=^5019745
 ;;^UTILITY(U,$J,358.3,53502,0)
 ;;=Z63.4^^247^2691^7
 ;;^UTILITY(U,$J,358.3,53502,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,53502,1,3,0)
 ;;=3^Bereavement
 ;;^UTILITY(U,$J,358.3,53502,1,4,0)
 ;;=4^Z63.4
 ;;^UTILITY(U,$J,358.3,53502,2)
 ;;=^5063168
 ;;^UTILITY(U,$J,358.3,53503,0)
 ;;=Z45.2^^247^2691^5
 ;;^UTILITY(U,$J,358.3,53503,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,53503,1,3,0)
 ;;=3^Adjustment & Management of VAD
 ;;^UTILITY(U,$J,358.3,53503,1,4,0)
 ;;=4^Z45.2
 ;;^UTILITY(U,$J,358.3,53503,2)
 ;;=^5062999
 ;;^UTILITY(U,$J,358.3,53504,0)
 ;;=Z76.0^^247^2691^16
 ;;^UTILITY(U,$J,358.3,53504,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,53504,1,3,0)
 ;;=3^Issue of Repeat Prescription
 ;;^UTILITY(U,$J,358.3,53504,1,4,0)
 ;;=4^Z76.0
 ;;^UTILITY(U,$J,358.3,53504,2)
 ;;=^5063297
 ;;^UTILITY(U,$J,358.3,53505,0)
 ;;=Z01.818^^247^2691^20
 ;;^UTILITY(U,$J,358.3,53505,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,53505,1,3,0)
 ;;=3^Pre-Op Call
 ;;^UTILITY(U,$J,358.3,53505,1,4,0)
 ;;=4^Z01.818
 ;;^UTILITY(U,$J,358.3,53505,2)
 ;;=^5062628
 ;;^UTILITY(U,$J,358.3,53506,0)
 ;;=Z51.81^^247^2691^21
 ;;^UTILITY(U,$J,358.3,53506,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,53506,1,3,0)
 ;;=3^Therapeutic Drug Level Monitoring
 ;;^UTILITY(U,$J,358.3,53506,1,4,0)
 ;;=4^Z51.81
 ;;^UTILITY(U,$J,358.3,53506,2)
 ;;=^5063064
 ;;^UTILITY(U,$J,358.3,53507,0)
 ;;=I10.^^247^2691^15
 ;;^UTILITY(U,$J,358.3,53507,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,53507,1,3,0)
 ;;=3^Hypertension
 ;;^UTILITY(U,$J,358.3,53507,1,4,0)
 ;;=4^I10.
 ;;^UTILITY(U,$J,358.3,53507,2)
 ;;=^5007062
 ;;^UTILITY(U,$J,358.3,53508,0)
 ;;=Z79.01^^247^2691^17
 ;;^UTILITY(U,$J,358.3,53508,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,53508,1,3,0)
 ;;=3^Long Term (Current) Use of Anticoagulants
